Skip to main content
News

Pharmacogenomics in Oncology: Unlocking Value, Safety, and ROI for Healthcare Systems

By October 29, 2025December 24th, 2025No Comments

“The future of oncology will not be determined only by novel therapies, but also by how effectively healthcare systems deliver them safely and affordably. Comprehensive PGx testing in oncology care, anchored in proper use of anticancer medications but extending across multiple drug classes, provides a proven mechanism to reduce severe toxicity, preserve treatment efficacy, and control costs.” – Houda Hachad, PharmD, M.Res

Houda’s article, Pharmacogenomics In Oncology: Unlocking Value, Safety, And ROI For Healthcare Systems, covers the scope and impact of PGx in oncology across multiple factors and variants. Read the full article in Healthcare Business Today: https://www.healthcarebusinesstoday.com/pharmacogenomics-oncology-roi/

Leave a Reply